TipRanks
Spago Nanomedical AB (DE:7UX)
FRANKFURT:7UX
Germany Market
7UX
Spago Nanomedical AB
RESEARCH TOOLSreports

Spago Nanomedical AB (7UX) Ratios

1 Followers

Spago Nanomedical AB Ratios

DE:7UX's free cash flow for Q2 2026 was kr0.00. For the 2026 fiscal year, DE:7UX's free cash flow was decreased by kr and operating cash flow was kr0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 7.25 6.96 6.58 4.52 7.42
Quick Ratio
 7.25 6.96 6.58 4.52 7.42
Cash Ratio
 6.40 5.74 5.54 3.94 7.06
Solvency Ratio
 -4.37 -4.44 -5.07 -3.59 -4.43
Operating Cash Flow Ratio
 -4.30 -5.48 -5.91 -3.91 -4.34
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
kr 30.84Mkr 30.00Mkr 32.24Mkr 40.24Mkr 56.45M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.19 1.19 1.19 1.28 1.04
Debt Service Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
 1.14 1.12 0.97 1.07 1.60
Profitability Margins
Gross Profit Margin
-46335.00%-4435.47%-646.68%-1935.41%-1480.46%
EBIT Margin
-71437.50%-6076.43%-1764.15%-3533.25%-3708.25%
EBITDA Margin
-71245.00%-6038.22%-1747.83%-3509.89%-3674.48%
Operating Profit Margin
-81622.50%-7062.70%-1764.15%-3926.27%-3744.31%
Pretax Profit Margin
-65710.00%-6076.43%-1701.15%-3509.81%-3718.88%
Net Profit Margin
-65710.00%-6076.43%-1701.15%-3509.81%-3729.51%
Continuous Operations Profit Margin
-65710.00%-6076.43%-1701.15%-3509.81%-3718.88%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.29%
EBT Per EBIT
80.50%86.04%96.43%89.39%99.32%
Return on Assets (ROA)
-69.79%-72.39%-82.13%-79.69%-19.09%
Return on Equity (ROE)
-106.23%-86.37%-97.82%-102.19%-19.94%
Return on Capital Employed (ROCE)
-100.21%-97.93%-99.98%-113.79%-20.02%
Return on Invested Capital (ROIC)
-100.21%-97.93%-99.98%-113.79%-20.02%
Return on Tangible Assets
-69.79%-72.39%-82.13%-79.69%-59.47%
Earnings Yield
-41.38%-60.81%-56.15%-65.89%-46.70%
Efficiency Ratios
Receivables Turnover
 0.18 3.74 0.41 0.26 0.34
Payables Turnover
 7.50 6.27 5.24 3.83 3.53
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.38 3.24 3.12 1.30 1.24
Asset Turnover
 <0.01 0.01 0.05 0.02 <0.01
Working Capital Turnover Ratio
 <0.01 0.01 0.05 0.02 0.02
Cash Conversion Cycle
 1.93K 39.53 819.86 1.31K 984.54
Days of Sales Outstanding
 1.98K 97.72 889.48 1.41K 1.09K
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 48.70 58.19 69.63 95.27 103.53
Operating Cycle
 1.98K 97.72 889.48 1.41K 1.09K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.03 -0.08 -0.12 -0.23 -0.29
Free Cash Flow Per Share
 -0.03 -0.08 -0.12 -0.23 -0.31
CapEx Per Share
 0.02 0.08 <0.01 <0.01 0.03
Free Cash Flow to Operating Cash Flow
 0.77 1.01 1.01 1.00 1.10
Dividend Paid and CapEx Coverage Ratio
 -1.51 -1.00 -151.39 -293.52 -9.97
Capital Expenditure Coverage Ratio
 -1.51 -1.00 -151.39 -293.52 -9.97
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
 -546.48 -64.75 -18.14 -37.33 -36.23
Free Cash Flow Yield
-21.99%-65.33%-60.27%-70.32%-49.91%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -2.03 -1.65 -1.78 -1.52 -2.14
Price-to-Sales (P/S) Ratio
 1.91K 99.92 30.30 53.26 79.87
Price-to-Book (P/B) Ratio
 2.01 1.42 1.74 1.55 0.43
Price-to-Free Cash Flow (P/FCF) Ratio
 -4.55 -1.53 -1.66 -1.42 -2.00
Price-to-Operating Cash Flow Ratio
 -2.91 -1.54 -1.67 -1.43 -2.20
Price-to-Earnings Growth (PEG) Ratio
 -0.03 0.05 0.04 0.06 0.06
Price-to-Fair Value
 2.01 1.42 1.74 1.55 0.43
Enterprise Value Multiple
 -1.54 -0.53 -0.76 -0.45 -0.57
Enterprise Value
 43.98M 13.99M 25.43M 18.86M 22.08M
EV to EBITDA
 -1.54 -0.53 -0.76 -0.45 -0.57
EV to Sales
 1.10K 32.02 13.31 15.68 20.95
EV to Free Cash Flow
 -2.61 -0.49 -0.73 -0.42 -0.53
EV to Operating Cash Flow
 -2.01 -0.49 -0.73 -0.42 -0.58
Tangible Book Value Per Share
 0.05 0.08 0.11 0.21 0.43
Shareholders’ Equity Per Share
 0.05 0.08 0.11 0.21 1.48
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 >-0.01
Revenue Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
 -0.04 -0.07 -0.11 -0.22 -0.29
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.92 1.00 0.96 0.99 1.00
Research & Development to Revenue
 305.82 26.27 7.47 20.35 16.22
SG&A to Revenue
 126.17 0.00 13.45 0.00 7.66
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.83 1.07 1.03 1.06 0.97
Currency in SEK